Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease （OCEAN PROJECT）
Conditions: Nonalcoholic Fatty Liver Disease; Chronic Hepatitis b Interventions: Drug: Peg-Interferon α Sponsors: First Affiliated Hospital of Wenzhou Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Efficacy and safety of azvudine in symptomatic adult COVID-19 participants who are at increased risk of progressing to critical illness: a study protocol for a multicentre randomized double-blind placebo-controlled phase III trial
DiscussionThe purpose of this clinical trial is to determine whether azvudine can prevent patients at risk of severe disease from progressing to critical illness and death, and the results will identify whether azvudine is an effective and affordable antiviral treatment option for COVID-19.Trial registrationClinicalTrials.gov NCT05689034. Registered on 18 January 2023. (Source: Trials)
Source: Trials - January 22, 2024 Category: Research Source Type: clinical trials
The Efficacy of Vosevi in Treating DAA-experienced Patients
Conditions: Chronic Hepatitis C; Antiviral Therapy Interventions: Drug: Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] Sponsors: The Third Affiliated Hospital of Guangzhou Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2023 Category: Research Source Type: clinical trials
A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B
Condition: Hepatitis B, Chronic Intervention: Other: Exposure factors Sponsors: Qilu Hospital of Shandong University; Linyi People's Hospital; First Affiliated Hospital Xi'an Jiaotong University; First Affiliated Hospital of Wenzhou Medical University; Third Affiliated Hospital, Sun Yat-Sen University; Sir Run Run Shaw Hospital; First Affil iated Hospital of Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy
Conditions: HBV; HCC Intervention: Drug: nucleoside analogues or interferon Sponsors: Wen-hong Zhang; Shandong Provincial Hospital Affiliated to Shandong First Medical University; First Affiliated Hospital Xi'an Jiaotong University; The Affiliated Hospital of Xuzhou Medical University; First Affiliated Hospital of Fujian Medical University; The Third People's H ospital of Taiyuan; The First People's Hospital of Yunnan; The First Affiliated Hospital of Anhui Medical University; Wuhan Union Hospital, China; The First Affiliated Hospital with Nanjing Medical University ...
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
